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Two Rules on the Protein-Ligand Interaction  
Xiaodong Pang1, 2†, Linxiang Zhou1†, Lily Zhang3, Lina Xu3 & Xinyi Zhang1, 2* 
So far, we still lack a clear molecular mechanism to explain the 
protein-ligand interaction on the basis of electronic structure of a protein. By 
combining the calculation of the full electronic structure of a protein along with 
its hydrophobic pocket and the perturbation theory, we found out two rules on 
the protein-ligand interaction. One rule is the interaction only occurs between 
the lowest unoccupied molecular orbitals (LUMOs) of a protein and the highest 
occupied molecular orbital (HOMO) of its ligand, not between the HOMOs of a 
protein and the LUMO of its ligand. The other rule is only those residues or 
atoms located both on the LUMOs of a protein and in a surface pocket of a 
protein are activity residues or activity atoms of the protein and the 
corresponding pocket is the ligand binding site. These two rules are derived from 
the characteristics of energy levels of a protein and might be an important 
criterion of drug design.  
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Understanding ruling principles of interactions between a target protein and a 
ligand is of paramount importance in drug discovery efforts. So far, in finding a real 
ligand for a given target protein, we are limited to experimental screening from a large 
number of small molecules, or through free energy calculation of assessing a ligand. 
However, we still lack a clear molecular mechanism to explain the protein-ligand 
interaction on the basis of electronic structure of a protein. Here we report two rules 
on the protein-ligand interaction using the full electronic structure calculation of a 
protein along with the perturbation theory of the interaction between two wave 
functions and the pocket calculation as a new means of drug design and exploring 
enzyme reaction.  
The full electronic structure calculation of a protein has been a challenge as the 
system of a protein is huge and complicated. We use the overlapping-dimer 
approximation (ODA)1-3 and the extended negative factor counting (ENFC)4 methods 
to calculate the electronic structure of a protein. These two methods were first 
developed by J. Ladik and Y. J. Ye et al1,4. We further clarified and revised some parts 
to facilitate calculations of proteins with over 600 residues.  
The ODA uses the divide and conquer (D&C) algorithm, which works by 
recursively breaking down a complex problem into many subproblems of the same (or 
related) type of the same scale. These subproblems are independent of each other, and 
their characters are the same as the original problem. We can use the solutions of 
these small subproblems to get the solution of the original problem. First of all, the 
whole chain of a protein is divided into many dimers, each containing two amino acid 
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residues, and then we can perform any quantum calculation methods for these dimers; 
finally, construct the full Hamiltonian matrix using the solution of each dimer and use 
the ENFC math method to get the energy eigenvalues and the orbital coefficients of 
the wave function of a protein. Additionally, the surrounding environment of each 
dimer and the water environment of a protein are applied in the process.  
We take the protein-ligand complex Cyclophilin A (CypA) and its ligand 
Cyclosporin A (CsA) and FKBP12 of the protein family FKBPs and its 
immunosuppressant FK506 as examples, and the results obtained are in good 
agreement with experiments. 
The system of a protein molecule is so large that the energy levels are extremely 
compact. Therefore, for a protein system, we need to extend the definition of the 
frontier orbitals to be a series of HOMOs and LUMOs, not just limited to be a single 
HOMO or LUMO. Ordinarily, the first 10 to 20 occupied molecular orbitals and the 
unoccupied ones are considered to be HOMOs and LUMOs. For example, the protein 
CypA has a total of 4807 occupied molecular orbitals. We considered the first 10 
highest occupied molecular orbitals to be its HOMOs and the first 10 lowest 
unoccupied molecular orbitals as its LUMOs. The 10 HOMOs comprise only 0.2% 
among total 4807 occupied molecular orbitals. 
 
RESULTS 
First rule of the protein-ligand interaction 
Figure 1 and Tables 1 and 2 express the partial results of the frontier orbitals and 
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orbital coefficients for CypA/CsA and FKBP12/FK506 separately (see 
Supplementary Tables 1 and 2 for more details about the frontier orbitals).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Schematic diagrams of the energy level. (a) Protein CypA interacts with ligand 
CsA at ground state. (b) Protein FKBP12 interacts with ligand FK506 at 300 K. The 
characteristics of energy level structure of a protein are that the LUMOs of a protein are 
always about 1.0 eV above the zero-energy-level, but its HOMOs are always far away 
below the zero-energy-level (about -10.0 eV). It is the very characteristics that result in the 
first rule. 
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Table 1 The first 10 LUMOs of CypA and FKBP12. The definition of occupancy at nth  
residue is   
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22 )(/)()( , where jC  are the orbital coefficients. 
Those residues that have 05.0)( <na  are neglected. The wave function localizes on a 
single residue, since the occupancy of each orbital is larger than 99%. For CypA, residue 
PHE60 and PHE113 are activity residues. For FKBP12, residue TRY26, PHE36, PHE46, 
PHE59, PHE82 and PHE99 are activity residues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Molecular orbital Energy band 
( eV ) 
Position of wave 
function 
( residues ) 
Occupancy 
4817 1.959 PHE36 0.996 
4816 1.956 PHE60 0.996 
4815 1.954 PHE113 0.995 
4814 1.930 PHE145 0.998 
4813 1.880 PHE53 0.998 
4812 1.866 PHE67 0.996 
4811 1.850 PHE53 0.997 
4810 1.849 TYR79 0.998 
4809 1.690 TYR48 1.000 
CypA 
4808 1.020 TRP121 0.996 
3169 2.261 PHE48 0.993 
3168 2.141 TYR26 0.998 
3167 2.109 PHE36 0.995 
3166 2.101 PHE82 0.998 
3165 1.988 PHE15 0.999 
3164 1.932 PHE46 0.999 
3163 1.811 PHE48 0.998 
3162 1.754 PHE99 0.997 
3161 1.620 PHE36 0.992 
FKBP12 
3160 1.328 TRP59 0.999 
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Table 2 The HOMO and LUMO of the ligand CsA and FK506. 
 Molecular orbital Energy band 
( eV ) 
Position of wave function 
( residues ) 
247 2.520 LEU6,ALA7,DLA8,LEU9 
CsA 
246 -3.519 MVA11 
842 2.314 
C8,C9,C10,C14,C19,C20,C22, 
C27,C28,N7,O3,O4,O5,O9 FK506 
841 -3.255 C2,C8,C9,C10,C11,N7,O3,O4,O6 
 
We define the energy difference between a protein and its ligand as 
ligandHOMOOproteinLUM EEE −≡Δ 1  , OproteinHOMligandLUMO EEE −≡Δ 2  , 
where, OproteinLUME  is the average value of the activity residues and OproteinHOME  is 
the highest value of HOMOs, ligandLUMOE  and ligandHOMOE  are values of the LUMO 
and the HOMO of ligand, respectively. 
The calculation result demonstrates as follows:  
for CypA/CsA, eVEeVE 80.12)29.10(52.248.5)52.3(96.1 21 =−−=Δ<=−−=Δ , 
for FKBP12/FK506, eVEeVE 38.12)07.10(31.259.4)26.3(33.1 21 =−−=Δ<=−−=Δ . 
Especially, we have to point out that the results of CypA/CsA and FKBP12/FK506 are 
examples only. We calculated other protein/ligand systems and obtained the same 
resulting relationship 21 EE Δ<Δ  as the above two systems without exception
5,6
. 
Therefore, the relationship 21 EE Δ<Δ  might be a generally correct in protein-ligand 
systems. 
According to the frontier orbital theory, the perturbation energy of interaction 
between two molecules mainly comes from the interaction between HOMO and 
LUMO. If the energy of a protein is different from the energy of its ligand, the effect 
of the interaction produces energy split. As a result, the smaller the energy difference 
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between two orbitals, the stronger the interaction. (Whether the interaction between 
two molecules can form a bond, it is related to the symmetry of the molecular orbital.) 
We can, therefore, deduce the first rule on the protein-ligand interaction: 
The protein-ligand interaction only occurs between the lowest unoccupied 
molecular orbitals (LUMOs) of a protein and the highest occupied molecular 
orbital (HOMO) of its ligand, not between the HOMOs of a protein and the 
LUMO of its ligand. 
Actually, it is the very characteristics of energy level structure of a protein that 
result in the first rule. The characteristics are that the LUMOs of a protein are always 
about 1.0 eV above the zero-energy-level, but its HOMOs are always far away below 
the zero-energy-level (about -10.0 eV). It is due to this kind of structure that the 
LUMOs of a protein are always near the HOMO of its ligand and the HOMOs of a 
protein are always far away from the LUMO of its ligand. That is why always there is 
the relationship 21 EE Δ<Δ  in the protein-ligand interaction. The first rule may be 
regarded as one of criteria of identifying a ligand. An interesting aside is that the wave 
function of a protein usually localizes on one or few residues (see the occupancy item 
on Table 1). 
Second rule of the protein-ligand interaction 
According to the first rule, as a necessary condition, the activity residues or activity 
atoms of a protein must be located on the LUMOs of the protein, but conversely, not 
every residue on the LUMOs is certainly the activity residue. When a ligand interacts 
with its target protein, it must enter into a pocket on the surface of the protein. For the 
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same reason, only the pocket which has its forming atoms located on the LUMOs is 
the ligand binding site. Therefore, on the basis of the full electronic structure of a 
protein along with the pocket calculation, we can derive the second rule that only 
those residues or atoms located both on the LUMOs of a protein and in a surface 
pocket of a protein are activity residues or activity atoms of the protein and the 
corresponding pocket is the ligand binding site. This is the necessary and sufficient 
condition for being the activity residues or activity atoms, as well as the ligand 
binding site. 
Now we can use this rule to check the activity atoms of a protein. We selected 
CASTp method7 to calculate the pockets. The CASTp is a geometry-based method of 
pocket detection, based on the alpha shape and discrete flow theory, and a related 
suite of programs. It can provide full descriptions of pockets on protein surface, 
including the atoms, residues, and volume of each pocket. For example, the CypA has 
a total of 19 pockets and the largest pocket is number 19. The FKBP12 has a total of 
13 pockets. Table 3 and Supplementary Table 3 show the pocket 19 of CypA and 
pocket 13 of FKBP12, respectively. Tables 4 and 5 and Supplementary Table 4 
describe activity atoms and their orbital coefficients of protein CypA, ligand CsA and 
FK506, and protein FKBP12, respectively.  
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Table 3 The forming atoms in the pocket 19 of CypA. Only the residues PHE60 and 
PHE113 are located on the LUMOs of CypA, and all other residues on the LUMOs of 
CypA are not located in other pockets. So, the pocket 19 is the ligand binding site and the 
PHE113 and PHE60 are the activity residues (From Supplementary Table 3, we know 
that the pocket 13 is the ligand binding site of FKBP12 and residue TRY26, PHE36, 
PHE46, PHE59, PHE82 and PHE99 are activity residues). 
 
 
 
 
 
 
 
 
 
 
 
Atom Res ID Atom Res ID 
NH1 ARG 55 CA ASN 102 
HH11 ARG 55 C ASN 102 
CE2 PHE 60 O ASN 102 
CZ PHE 60 N ALA 103 
CG MET 61 CB ALA 103 
SD MET 61 CB THR 107 
CG GLN 63 O THR 107 
CD GLN 63 N GLY 109 
OE1 GLN 63 CA GLY 109 
NE2 GLN 63 N SER 110 
HE21 GLN 63 N GLN 111 
O GLY 72 CB GLN 111 
CA THR 73 CG GLN 111 
C THR 73 CD GLN 111 
O THR 73 OE1 GLN 111 
 
CA GLY 74 NE2 GLN 111 
C GLY 74 HE21 GLN 111 
O GLY 74 HE22 GLN 111 
CA GLY 75 CB PHE 113 
C GLY 75 CG PHE 113 
O GLY 75 CD1 PHE 113 
CA LYS 76 CD2 PHE 113 
OE1 GLU 81 CE1 PHE 113 
O GLU 81 CE2 PHE 113 
CG LYS 82 CZ PHE 113 
CE LYS 82 CD1 LEU 122 
CA ALA 101 HD13 LEU 122 
CB ALA 101 CD2 LEU 122 
C ALA 101 HD21 LEU 122 
O ALA 101 HD22 LEU 122 
N ASN 102 CE1 HSD 126 
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Table 4 Orbital coefficient of the activity residue PHE113 and PHE60 of CypA on the 
LUMOs. Those atoms that have the absolute value of orbital coefficient less than 0.1 are 
neglected. Therefore, atom CE2 of PHE60 and atom CG, CD1, CD2, CE1, CE2 and CZ of 
PHE113 are the activity atoms. (AR: Activity Residue; AO: Atomic Orbital; OC: Orbital 
Coefficient) 
AR Atom AO OC 
CD1 2X -0.440 
 2Y 0.114 
 2Z -0.403 
CD2 2X 0.439 
 2Y -0.112 
 2Z 0.398 
CE1 2X 0.434 
 2Y -0.112 
 2Z 0.396 
CE2 2X -0.457 
 2Y 0.116 
PHE60 
 2Z -0.419 
CA 2S -0.145 
 2X 0.100 
 2Z 0.102 
HB 1S 0.147 
CG 2X 0.211 
 2Y -0.494 
 2Z 0.420 
CD1 2X -0.153 
 2Y 0.386 
 2Z -0.307 
CD2 2Y 0.121 
CE1 2Y 0.112 
CE2 2X -0.149 
 2Y 0.387 
 2Z -0.293 
CZ 2X 0.192 
 2Y -0.496 
PHE113 
 2Z 0.384 
 11 
Table 5 Orbital coefficient of activity atoms of CsA and FK506 on the HOMO. Those atoms 
that have the absolute value of orbital coefficient less than 0.1 are neglected. The residue 
MVA11 is the activity residue of CsA with four activity atoms: N, CA, C and O. FK506 has 
nine activity atoms: C2, C8, C9, C10, C11, N7, O3, O4 and O5. 
 
CsA FK506 
MVA11: N 2Pz -0.144 C2 2Py -0.123  N7 2S 0.100 
MVA11: CA 2S 0.211 C8 2S -0.151  2Px -0.120  
 2Px 0.160  2Py -0.235   2Pz 0.123  
 2Py -0.313 C9 2Py 0.151  O3 2Px -0.111  
 2Pz -0.154  2Pz 0.132   2Py 0.378  
MVA11: C 2S -0.380 C10 2S 0.147 O4 2Py -0.451  
 2Py 0.337  2Py -0.117   2Pz -0.441  
 2Pz -0.443  2Pz -0.331  O6 2Pz 0.112  
MVA11: O 2Py -0.341 C11 2Pz 0.113     
 2Pz 0.362       
  
We can see that none but the residues PHE60 and PHE113 are located not only 
on the LUMOs of CypA, but also in the pocket 19 (compare Table 1 and Table 3). All 
other residues on the LUMOs of CypA are not located in any other pocket. Therefore, 
we can say that the pocket 19 is the ligand binding site and the PHE113 and PHE60 
are the activity residues or that there are seven activity atoms: PHE113: CG, CD1, 
CD2, CE1, CE2, and CZ (these six atoms form a quincunx in Fig. 2a,b), and 
PHE60:CE2 as shown in Table 4. Though the atoms PHE113: CB, PHE113: CZ and 
PHE60: CZ are located on the LUMOs and in the pocket 19, their orbital coefficients 
are zero (Table 4), thus they are not activity atoms. Similarly, though the atoms 
PHE113: CA and PHE113: HB located on the LUMOs of CypA, they are not activity 
atoms because they are not located in the pocket 19.  
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It has been reported8 that CsA interacted with ARG55, PHE60, MET61, 
GLN63, GLY72, ALA101, ASN102, ALA103, GLN111, PHE113, TRP121, 
LEU122 and HIS126 of CypA. The ligand binding pocket obtained by our method is 
number 19, which comprises ARG55, PHE60, MET61, GLN63, GLY72, THR73, 
GLY74, GLY75, LYS76, GLU81, LYS82, ALA101, ASN102, GLN111, PHE113, 
LEU122 and HIS126. They are in good agreement.  
We can obtain the activity residues of FKBP12 by the same way: TYR26, 
PHE36, PHE46, TRP59, PHE82 and PHE99 (compare Table 1 and Supplementary 
Table 3), as well as the activity atoms as shown in Supplementary Table 4. 
Therefore, the pocket 13 is the ligand binding site of FKBP12. 
X-ray experiment9 reported that the binding pocket of FKBP12 comprised the 
residues TYR26, PHE46, PHE99, VAL55, ILE56 and TRP59. The activity residues 
we worked out are TYR26, PHE36, PHE46, TRP59, TRY82 and PHE99. They are 
also in good agreement. 
The residue MVA11 of the ligand CsA is on the HOMO of CsA. Therefore, 
MVA11 is the activity residue of CsA. Four atoms of residue MVA11 on the HOMO 
with the absolute value of its atomic coefficient larger than 0.1 are considered to be 
the activity atoms of the CsA: MVA11:N, MVA11:CA, MVA11:C and MVA11:O. 
And the activity atoms of FK506 are: C2, C8, C9, C10, C11, N7, O3, O4 and O6 
(Table 5). 
Figure 2 shows the spatial configuration of the ligand binding pocket and the 
activity atoms of CypA, CsA, FKBP12 and FK506. The activity atoms of ligand are 
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fitting so well with the activity atoms of protein that indicates strong interactions 
between them (Fig. 2b, d). Especially, as NMR experiment pointed out10, the CsA 
changed its configuration so that its activity residue MVA11 (the projecting part of the 
loop as shown in Fig. 2a) clearly trended toward the activity part of CypA.  
 
 
Figure 2 Spatial configurations of binding pockets and activity atoms (AA). (a) The binding 
pocket of protein CypA and backbone of ligand CsA. The activity residue MVA11 (the 
projecting part of the loop) of CsA clearly trends toward the activity part of CypA. (b) There 
are seven activity atoms of CypA, PHE113: CG, CD1, CD2, CE1, CE2, CZ (these six 
atoms form a quincunx in the bottom of the pocket.) and PHE60: CE2; and four activity 
atoms of CsA, MVA11: N, CA, C, O. (c) AA of FK506 (colored in gray to distinguish them 
from the binding pocket) fit well into the binding pocket of protein FKBP12. (d) There are 
nine activity atoms of FK506 and sixteen activity atoms of FKBP12 (see Table 5 and 
Supplementary Table 4). The activity atoms of FK506 are enclosed by the activity atoms 
of FKBP12 
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DISCUSSION 
Assuming we now have a new target protein, we can work out its LUMOs and 
pockets only from its coordinate file called pdb file, and we can immediately obtain 
its ligand binding site, activity residues and activity atoms. Then we can help identify 
which small molecules can be its ligand by checking its HOMO energy. If its HOMO 
energy is far away from the LUMOs energy of the target protein, we are sure this 
small molecule can not be its ligand. 
These two rules enable us to have a clearer understanding of the mechanism of 
protein-ligand interaction on the basis of full electronic structure of a protein. The real 
reason which created these rules is due to the characteristics of energy level structure 
of a protein. They might be an important criterion for identifying or designing a 
ligand for a target protein. The first rule tells us the necessary condition for being the 
activity residues or activity atoms that they must locate on the LUMOs of a protein, 
and permits us to identify a ligand by checking its HOMO energy level. We can use 
the energy eigenvalues and orbital coefficients of the wave function to calculate many 
other characteristics of a protein. The second rule points out the necessary and 
sufficient condition for being the activity residues/atoms and the ligand binding site. 
Therefore, it allows us to identify not only the ligand binding site, but also the activity 
residues and activity atoms of a protein. When detecting the activity pocket, its 
volume and mouth-area can also help us identify a ligand.  
We anticipate our method to be a starting point, which contributes to the study of 
the protein-ligand interaction and can assist the drug design on the basis of electronic 
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structure, and provides us with a more detailed understanding of the mechanism of 
protein-ligand interaction.  
 
METHODS 
Molecular Dynamic (MD) Simulation. Complex CypA/CsA and 
FKBP12/FK506 were performed MD simulation to obtain the ground state and the 
state of 300 K, respectively. Their starting coordinates were taken from the protein 
database bank11 (PDB) with entry 1CWK and 1FKJ, respectively. The parallel MD 
program we used is NAMD12 and all the molecules were solvated before the MD 
simulation. 
However, for a ligand or other small molecules, there is often no topology and 
parameter information in the standard CHARMM’s library. In that case, the web site 
HIC-UP13 can help us to find the topology and parameter files for these small 
molecules. These files are X-PLOR version14, not CHARMM version. The ligand 
FK506 was treated in this way. 
For ligand CsA, a cyclic undecapeptide with the following primary structure: 
MeBmt1-Abu2-Sar3-MeLeu4-Val5-MeLeu6-Ala7-D-Ala8-MeLeu9-MeLeu10-MeVal
11. Residues 1, 3, 4, 6, 9, 10 and 11 are N-methylated on the amide nitrogen. Here, we 
created its topology and parameter information based on existing topology 
information from other molecules. 
The basic idea to create the topology file of CsA is as follows: 
(1). For residues MeBmt1 and Abu2, of which both not belong to the 20 kinds of 
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standard resides of protein, we need to write out their topology files. Details of 
creating those two topology files can be found at the book6 from page 125 to 139.  
(2). We used program PSFGEN12 to build the protein data base (PDB) file and 
protein structure file (PSF) of CsA by using a patch LINK to link MeBmt1 and 
MeVal11 since it’s a cyclic molecule and a patch METH to methylate the amide 
nitrogen of resides 1, 3, 4, 6, 9, 10 and 11. 
After we get the topology file of CsA, we can use the program PSFGEN to build 
its new PDB and PSF files. PSFGEN, a CHARMM version, can generate a revised 
PDB and PSF files with hydrogen atoms added, as well as the water environment 
For protein CypA, consisting of 165 residues and 2053 atoms, we also used the 
PSFGEN to get its new PDB and PSF files. 
Finally, we set up the configuration file to run the MD simulation. The 
parameters for CHARMM force field was selected as follows: exclude = scaled 4, 1-4 
scaling = 1.0, switching = on, switchdist = 8 Å, cutoff = 12 Å, pairlestdist = 13.5. We 
minimized the CypA and CsA for 80ps, separately. 
For ligand FK506, with chemical formula C44H69NO12, we get its topology 
and parameter files from HIC-UP server and run program XPLOR6413 to get its new 
PDB and PSF file. The XPLOR64, a XPLOR version, can generate a revised PDB 
and PSF files using topology file obtained from CNS13. 
For protein FKBP12, we also used XPLOR to generate its new PDB and PSF 
files. 
We select the same MD parameters as CypA/CsA for FKPB12 and FK506 
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separately. They were firstly relaxed to near 20 K by running 20 ps. And then it was 
heated continuously from 20K to 290K with the temperature step 30 K, running 30 ps 
for each step. And we performed a smaller temperature step 5 K from 295 K to 300 K 
with 30 ps each step. Finally, run 50 ps at 300 K. The total time scale is 520 ps for the 
whole process using 16 CPUs. 
Full Electronic Structure Calculation. We used ODA and a math method 
ENFC to calculate the electronic structure of protein CypA (165 residues) and 
FKBP12 (107 residues). After MD simulation, we obtained the coordinates of the 
proteins and ligands at temperature of interest. We needed to transform the format of 
these pdb files into ODA format. Then, we followed the four steps of ODA mentioned 
above to calculate their eigenvalues, orbital coefficients of wave functions and density 
of state (DOS).  
We used program ArgusLab15 to calculate the HOMO and the LUMO of ligand 
CsA and FK506.  
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